InMode (INMD) Current Deferred Tax Assets (2018 - 2026)

InMode (INMD) posted quarterly Current Deferred Tax Assets of $52.9 million for Q1 2026, down 0.58% on a QoQ basis from $53.2 million in Q4 2025.

InMode (INMD) Current Deferred Tax Assets (2018 - 2026) Analysis & Trends

InMode (INMD) has reported Current Deferred Tax Assets for 4 consecutive years, with $52.9 million the latest figure, recorded in Q1 2026.

  • Quarterly Current Deferred Tax Assets changed N/A year-over-year to $52.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.9 million (changed N/A YoY) and the FY2025 annual result came in at $53.2 million, changed N/A from the prior year.
  • Current Deferred Tax Assets retreated to $52.9 million in Q1 2026 per INMD's latest filing, from $53.2 million in the prior quarter.
  • Over the last five years, Current Deferred Tax Assets for INMD reached as high as $53.2 million in Q4 2025 and fell as low as $52.9 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 InMode 956,721.10 -479.17 Mn 61.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 52.92 Mn
Mar 31, 2026 52.92 Mn
Dec 31, 2025 53.23 Mn
Dec 31, 2025 53.23 Mn
Sep 30, 2019 47,000.00
Sep 30, 2019 47,000.00
Jun 30, 2019 57,000.00
Jun 30, 2019 57,000.00
Dec 31, 2018 11,000.00
Dec 31, 2018 11,000.00